Evaluation of Drugs for Listing Purposes

The evaluation of drugs for listing purposes was updated in July 2018 following recent developments in the area of drug evaluation and new, innovative therapies.


Document modalités d'évaluation

This document explains the drug evaluation approach used at INESSS. It includes a description of the basic principles that apply to all products that we assess for listing purposes.

Subscribe to our newsletter now